Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.2100
0.00 (0.00%)
Apr 7, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 168.57 million as of April 7, 2026. Its market cap has increased by 923.65% in one year.
Market Cap
168.57M
Enterprise Value
173.78M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 168.57M, a decrease of -14.30%. That is a compound annual growth rate of -3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 168.57M | -24.87% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | 196.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 734.10M |
| PolyNovo | 645.94M |
| Aroa Biosurgery | 200.38M |
| EMVision Medical Devices | 148.70M |
| Epiminder | 133.60M |
| SomnoMed | 129.26M |
| Cleo Diagnostics | 75.96M |
| Compumedics | 54.93M |